Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Consortium for Optimized Integration of Bio-Artificial Blood Components for Adaptive Resuscitation Therapy

NCT05756426 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT05756426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05756426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Consortium for Optimized Integration of Bio-Artificial Blood Components for Adaptive Resuscitation Therapy
Lead sponsor
University of Maryland, Baltimore
Phase
Observational
Overall status
Active, not recruiting
Start date
April 13, 2023
Completion date
January 30, 2029
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodynamic instability, hemorrhage